August 03, 2011. Moscow, Russia. Cromos Pharma announces addition of a new service – supply of comparator drugs for clinical trials.
“We have noticed that our sponsors frequently experience significant difficulties in obtaining comparator drugs on the Russian market” – said Dr. Vlad Bogin, MD, CEO of Cromos Pharma. “There exist a lack of understanding of who the right local partners are, delays in execution of purchases, and most importantly, unjustifiably high prices”.
Through its network of collaborators Cromos Pharma will provide comparator drugs for clinical trials conducted in Russia. “We have very close relationships with all major distributors and can negotiate very attractive discounts, thus offering significant savings to pharmaceutical companies. Moreover we can deliver drugs directly to sites via courier service of our partner in 3C Alliance.” – said Dr. Tarakanov, MD, head of company’s Russian office.
About Cromos Pharma LLC.
Cromos Pharma, LLC is a contract research organization (CRO) with operations in Russia and Eastern Europe and a business development office in the United States. The company provides a full spectrum of trial-related services which include regulatory approvals, medical writing, feasibility assessments, monitoring, project management and warehousing. Cromos Pharma LLC is a privately owned company.
Tuesday 1 December marked World AIDS Day 2020. Although throughout this year our focus has been on the coronavirus pandemic, World AIDS Day is an opportunity to reflect on another pandemic where a virus passed from animals to humans with devastating consequences. To date 77 million people worldwide have been infected with HIV. In spite of innovative new treatments 35 million people have died from the virus.
If you missed the live webinar “Where in the world should I locate my pivotal clinical trial?” you can now watch the recording by clicking here. The webinar hosted by the Society of Physician Entrepreneurs (SoPE) and Workforce Genetics features Cromos Pharma's CEO Vlad Bogin, M.D, FACP.